BRIEF published on 08/28/2024 at 13:05, 21 days 13 hours ago Starrex International Announces Inability To File Q2 Financials on Time Cease Trade Order Starrex International Q2 Financials Litigation Impact Stock Halt
BRIEF published on 08/28/2024 at 13:05, 21 days 13 hours ago Starrex International annonce son incapacité à déposer ses résultats financiers du deuxième trimestre à temps Starrex International Résultats Financiers Du Deuxième Trimestre Ordre De Cessation D'activité Impact Du Litige Arrêt Des Stocks
PRESS RELEASE published on 08/28/2024 at 13:00, 21 days 13 hours ago Starrex International Announces Inability To File Q2 Financials on Time Starrex International, Ltd. announces delay in filing financial statements, anticipates cease trade order due to litigation impact. Company provides contact information and advises on stock status Financial Statements Cease Trade Order Litigation Starrex International Stock Status
BRIEF published on 08/06/2024 at 13:20, 1 month 12 days ago Starrex International Announces Appointment of Independent Director Independent Director Board Appointment Starrex International David Lowe Business Experience
BRIEF published on 08/06/2024 at 13:20, 1 month 12 days ago Starrex International annonce la nomination d'un administrateur indépendant Starrex International Nomination Au Conseil D'administration Administrateur Indépendant David Lowe Expérience En Affaires
PRESS RELEASE published on 08/06/2024 at 13:15, 1 month 12 days ago Starrex International Announces Appointment of Independent Director Starrex International, Ltd. appoints David Lowe as independent Canadian director with extensive business experience and public company background. The Board welcomes his valuable input Board Of Directors Starrex International David Lowe Business Experience Public Company
PRESS RELEASE published on 02/06/2024 at 13:15, 7 months 12 days ago Starrex International Announces Resignation of President Starrex International, Ltd. announces resignation of President & CEO, appointment of Charles Burns as interim CEO, and commitment to expansion in the United States Title industry Interim CEO Expansion Resignation Starrex International United States Title Industry
PRESS RELEASE published on 12/15/2023 at 15:45, 9 months 3 days ago Starrex International Reaches Settlement on Outstanding Credit Facility
PRESS RELEASE published on 12/11/2023 at 15:05, 9 months 7 days ago Starrex International Faces Summary Judgement Application on Demand for Repayment of Credit Facility
PRESS RELEASE published on 10/18/2023 at 16:00, 11 months ago Starrex International Announces Demand for Repayment of Credit Facility
Published on 09/18/2024 at 23:10, 3 hours 8 minutes ago Ur-Energy Provides Operations, Construction and 2024 Guidance Updates
Published on 09/18/2024 at 23:00, 3 hours 18 minutes ago Garden State Gold & Coin Applauds Passage of Historic NJ Sales Tax Bill on Precious Metals
Published on 09/18/2024 at 21:15, 5 hours 3 minutes ago New to the Street Launches 24-Part Series with ARAX Holdings, Spotlighting Core Blockchain, CorePass, Lunaº Mesh, and Revolutionary Tech Solutions
Published on 09/18/2024 at 21:00, 5 hours 18 minutes ago Falcon Commences Drilling At Its Great Burnt Copper Project, NL
Published on 09/18/2024 at 16:30, 9 hours 48 minutes ago Manimal Tales Launches New Nursery Rhyme Based Detective Series: Your Child Solves Nursery Crimes in our Newest Personalized Book!
Published on 09/18/2024 at 19:11, 7 hours 6 minutes ago EQS-Adhoc: alstria office REIT-AG: squeeze-out demand regarding the shares of minority shareholders, amendment to investment agreement, loss of REIT-status at year-end 2024
Published on 09/18/2024 at 18:45, 7 hours 32 minutes ago Fuller, Smith & Turner PLC: Transaction in own shares
Published on 09/18/2024 at 18:31, 7 hours 46 minutes ago EQS-Adhoc: Vonovia SE: Initiation of the process to conclude a domination and profit and loss transfer agreement between Vonovia SE and Deutsche Wohnen SE
Published on 09/18/2024 at 18:13, 8 hours 4 minutes ago BILENDI: Creating discussion guides for market research is now possible with AI, thanks to BARI and Bilendi Discuss
Published on 09/18/2024 at 17:21, 8 hours 56 minutes ago EQS-Adhoc: Marinomed Biotech AG resolves capital increase excluding statutory subscription rights by issuing 154,053 no-par value bearer shares at an issue price of EUR 5 per share
Published on 09/18/2024 at 18:45, 7 hours 32 minutes ago Augmentation de capital consécutive à l'attribution gratuite d'actions aux salariés du groupe EuropaCorp
Published on 09/18/2024 at 18:45, 7 hours 32 minutes ago Capital increase following the allocation of free shares to EuropaCorp employees
Published on 09/18/2024 at 17:40, 8 hours 38 minutes ago Groupe CRIT : Modalités de mise à disposition du Rapport Financier semestriel 2024.